Lessons Learned from Coronavirus Disease 2019 (COVID-19) Therapies: Critical Perspectives From the Infectious Diseases Society of America (IDSA) COVID-19 Treatment Guideline Panel

Despite the challenges of the pandemic, there has been substantial progress with coronavirus disease 2019 (COVID-19) therapies. Pivotal COVID-19 trials like SOLIDARITY, RECOVERY, and ACCT-1 were rapidly conducted and data disseminated to support effective therapies. However, critical shortcomings re...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhimraj, Adarsh, Morgan, Rebecca L, Shumaker, Amy Hirsch, Baden, Lindsey, Chi-Chung Cheng, Vincent, Edwards, Kathryn M, Gandhi, Rajesh T, Gallagher, Jason C, Muller, William J, O’Horo, John C, Shoham, Shmuel, Wollins, Dana Swartzberg, Falck-Ytter, Yngve
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Viewpoints
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574532/
https://www.ncbi.nlm.nih.gov/pubmed/34668008
http://dx.doi.org/10.1093/cid/ciab882

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574532/
https://www.ncbi.nlm.nih.gov/pubmed/34668008
http://dx.doi.org/10.1093/cid/ciab882

Ejemplares similares